Larry Smith

[Larry Smith @SmithOnStocks1]

$nwbo I have taken the transcript from Linda Power’s comments at the annual meeting and edited and organized them to make for easier reading. It contains a wealth of valuable information. I have also included my key takeaways. The report is free . https://t.co/xRORGeau42

[Larry Smith @SmithOnStocks1]

The decision on Citadel, et al's motion to dismiss is likely to be released in four to six weeks. This leads me to republish a report on this issue earlier this year. https://t.co/MU6eqJKOIL

[Larry Smith @SmithOnStocks1]

$NWBO I have just published a new report on the lawsuit. It can be accessed at this link. https://t.co/MU6eqJKgTd Ignore the message that you need to subscribe to access the report. It is free.

[Larry Smith @SmithOnStocks1]

@andrewrsorkin

[Larry Smith @SmithOnStocks1]

I published a report last week "Highly Probable UK Approval of DCVax-L in 1H, 2024 Would Be a Crowning Achievement" for Northwest Biotherapeutics https://t.co/DFO5oBKC3L Firewall issues prevented some from seeing it, but this has been corrected. The report is free.

[Larry Smith @SmithOnStocks1]

@bikenfly62 @Doc_Hieu @SmithOnStocks Click on the link given in the tweet, This should avoid the paywall

[Larry Smith @SmithOnStocks1]

$nwbo I have summarized my latest thoughts on NWBO in a report “Highly Probable UK Approval of DCVax-L in 1H, 2024 Would Be a Crowning Achievement for Northwest Biotherapeutics”. This can be accessed free of charge at this link. https://t.co/DFO5oBKC3L

[Larry Smith @SmithOnStocks1]

@woodman267 Click on the link given in the tweet, This should avoid the paywall.

[Larry Smith @SmithOnStocks1]

@enaxor I told all subscribers that they need to cancel the automatic renewal function on PayPal. I can not do that. I will refund your money. Is your subscriber name enaxor or something else?

[Larry Smith @SmithOnStocks1]

I wrote this report on the importance of the approval for the commercial manufacturing of DCVax-L at Sawston last April. Thought I would republish. https://t.co/JcbB5Plv86

[Larry Smith @SmithOnStocks1]

@RPD60 @hoffmann6383 All records on trading are at the DTCC which is responsible for all trading and clearing of US stocks. It is a private company owned and operated by Wall Street firms. It is totally opaque. So the answer to your question is that at this time we can only infer.

[Larry Smith @SmithOnStocks1]

@hoffmann6383 Wall Street trading as practiced by all market makers is the biggest criminal operation on earth by a very wide margin.

[Larry Smith @SmithOnStocks1]

@NorthVanVic @ATLnsider UCLA has a small GMP facility for cell based therapies which was used in this trial. The purpose of the trial is to show proof of concept. Could it be used as the basis for seeking approval after DCVax-L is approved. Maybe.

[Larry Smith @SmithOnStocks1]

$nwbo Why I believe that NWBO has been the subject of a collusion between market makers and hedge funds to artificially drive the price to levels orders of magnitude below it would be without the manipulation. https://t.co/JhsQ7cFnxC

[Larry Smith @SmithOnStocks1]

@BossBlunts1 One of several widely (universally) employed tactics used by market makers to create counterfeit shares and manipulate stocks. Walls street trading is the largest criminal enterprise on earth be a wide measure.

[Larry Smith @SmithOnStocks1]

@Doc_Hieu Do you know what n is for this study. Also, when was the first and last patient enrolled.

[Larry Smith @SmithOnStocks1]

@BossBlunts1 Every market maker routinely does this.

[Larry Smith @SmithOnStocks1]

$nwbo The commercial licensing of Sawston likely confers to it a value of several hundred million dollars. This is a new and very important part of the NWBO inv thesis apart from DCVax-L. See my report. https://t.co/JcbB5Pm2XE

[Larry Smith @SmithOnStocks1]

@Hygro10 @SchlangDaddy Desperado.
Why don't you come to your senses?

[Larry Smith @SmithOnStocks1]

$nwbo Feuerstein continues to gaslight the DCVax-L phase 3 trial falsely claiming that the endpoint was PFS. Here are the actual facts. https://t.co/u2v1r5tooO

[Larry Smith @SmithOnStocks1]

@LoraPerry20 Citadel as part of its defence is claiming that it t relied on Feuerstein's research. Hence, Cohen Milstein can depose him and gain access to his records. Interesting to see where that goes.